The mitochondrial chaperone TRAP1 has been involved in several mitochondrial functions, and modulation of its expression/activity has been suggested to play a role in the metabolic reprogramming distinctive of cancer cells. TRAP1 posttranslational modifications, i.e. phosphorylation, can modify its capability to bind to different client proteins and modulate its oncogenic activity. Recently, it has been also demonstrated that TRAP1 is S-nitrosylated at Cys501, a redox modification associated with its degradation via the proteasome. Here we report molecular dynamics simulations of TRAP1, together with analysis of long-range structural communication, providing a model according to which Cys501 S-nitrosylation induces conformational changes to distal sites in the structure of the protein. The modification is also predicted to alter open and closing motions for the chaperone function. By means of colorimetric assays and site directed mutagenesis aimed at generating C501S variant, we also experimentally confirmed that selective S-nitrosylation of Cys501 decreases ATPase activity of recombinant TRAP1. Coherently, C501S mutant was more active and conferred protection to cell death induced by staurosporine. Overall, our results provide the first in silico, in vitro and cellular evidence of the relevance of Cys501 S-nitrosylation in TRAP1 biology.

Faienza, F., Lambrughi, M., Rizza, S., Pecorari, C., Giglio, P., Viloria, J., et al. (2020). S-nitrosylation affects TRAP1 structure and ATPase activity and modulates cell response to apoptotic stimuli. BIOCHEMICAL PHARMACOLOGY, 176, 113869 [10.1016/j.bcp.2020.113869].

S-nitrosylation affects TRAP1 structure and ATPase activity and modulates cell response to apoptotic stimuli

Faienza F;Rizza S;Giglio P;Pacello F;Battistoni A;Filomeni G
2020-01-01

Abstract

The mitochondrial chaperone TRAP1 has been involved in several mitochondrial functions, and modulation of its expression/activity has been suggested to play a role in the metabolic reprogramming distinctive of cancer cells. TRAP1 posttranslational modifications, i.e. phosphorylation, can modify its capability to bind to different client proteins and modulate its oncogenic activity. Recently, it has been also demonstrated that TRAP1 is S-nitrosylated at Cys501, a redox modification associated with its degradation via the proteasome. Here we report molecular dynamics simulations of TRAP1, together with analysis of long-range structural communication, providing a model according to which Cys501 S-nitrosylation induces conformational changes to distal sites in the structure of the protein. The modification is also predicted to alter open and closing motions for the chaperone function. By means of colorimetric assays and site directed mutagenesis aimed at generating C501S variant, we also experimentally confirmed that selective S-nitrosylation of Cys501 decreases ATPase activity of recombinant TRAP1. Coherently, C501S mutant was more active and conferred protection to cell death induced by staurosporine. Overall, our results provide the first in silico, in vitro and cellular evidence of the relevance of Cys501 S-nitrosylation in TRAP1 biology.
2020
Pubblicato
Rilevanza internazionale
Articolo
Nessuno
Settore BIO/10 - BIOCHIMICA
English
Allostery
Chaperone
Mitochondria
Molecular dynamics
Nitric oxide
Adenosine Triphosphatases
Animals
Binding Sites
Cysteine
Humans
Mitochondria
Molecular Dynamics Simulation
Mutation
Nitric Oxide
Proteasome Endopeptidase Complex
Protein Conformation
TNF Receptor-Associated Factor 1
Zebrafish
Zebrafish Proteins
Apoptosis
Protein Processing, Post-Translational
https://doi.org/10.1016/j.bcp.2020.113869
Faienza, F., Lambrughi, M., Rizza, S., Pecorari, C., Giglio, P., Viloria, J., et al. (2020). S-nitrosylation affects TRAP1 structure and ATPase activity and modulates cell response to apoptotic stimuli. BIOCHEMICAL PHARMACOLOGY, 176, 113869 [10.1016/j.bcp.2020.113869].
Faienza, F; Lambrughi, M; Rizza, S; Pecorari, C; Giglio, P; Viloria, J; Allega, M; Chiappetta, G; Vinh, J; Pacello, F; Battistoni, A; Rasola, A; Papal...espandi
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
859629v1.full.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Non specificato
Dimensione 1.91 MB
Formato Adobe PDF
1.91 MB Adobe PDF Visualizza/Apri
Biochem Pharmacol 2020a.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 7.27 MB
Formato Adobe PDF
7.27 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/295509
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 19
social impact